{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T01:36:26Z","timestamp":1648604186503},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.remn.2017.10.001","type":"journal-article","created":{"date-parts":[[2017,11,12]],"date-time":"2017-11-12T16:46:25Z","timestamp":1510505185000},"page":"156-162","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Aportaci\u00f3n de la PET\/TC con 11 C-colina en la recidiva bioqu\u00edmica del c\u00e1ncer de pr\u00f3stata con ant\u00edgeno espec\u00edfico prost\u00e1tico s\u00e9rico inferior a 1 ng\/ml"],"prefix":"10.1016","volume":"37","author":[{"given":"F.J.","family":"G\u00f3mez-de la Fuente","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Mart\u00ednez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"de Arcocha-Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Quirce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Jim\u00e9nez-Bonilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Mart\u00ednez-Amador","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Banzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.remn.2017.10.001_bib0150","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s12094-016-1607-9","article-title":"Cancer incidence in Spain, 2015","volume":"19","author":"Galceran","year":"2017","journal-title":"Clin Transl Oncol."},{"key":"10.1016\/j.remn.2017.10.001_bib0155","doi-asserted-by":"crossref","first-page":"49S","DOI":"10.2967\/jnumed.115.170126","article-title":"Evaluation of prostate cancer with 11C-choline PET\/CT for treatment planning, response assessment, and prognosis","volume":"57","author":"Ceci","year":"2016","journal-title":"J Nucl Med."},{"key":"10.1016\/j.remn.2017.10.001_bib0160","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.eururo.2013.05.025","article-title":"Management of biochemical recurrence after primary treatment of prostate cancer: A systematic review of the literature","volume":"64","author":"Punnen","year":"2013","journal-title":"Eur Urol."},{"key":"10.1016\/j.remn.2017.10.001_bib0165","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.acuroe.2015.03.009","article-title":"(11)C-choline\u00a0PET\/CT and multiparametric MRI in patients with biochemical relapse of prostate cancer","volume":"39","author":"Garc\u00eda","year":"2015","journal-title":"Actas Urol Esp."},{"key":"10.1016\/j.remn.2017.10.001_bib0170","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/RLU.0000000000000826","article-title":"11C-choline and 18F-FDG PET\/CT in the detection of occult prostate cancer in the context of a paraneoplastic syndrome","volume":"40","author":"Jim\u00e9nez-Bonilla","year":"2015","journal-title":"Clin Nucl Med."},{"key":"10.1016\/j.remn.2017.10.001_bib0175","first-page":"241","article-title":"Role of 18F-choline PET\/CT in guiding biopsy in patients with risen PSA levels and previous negative biopsy for prostate cancer","volume":"36","author":"Jim\u00e9nez Londo\u00f1o","year":"2017","journal-title":"Rev Esp Med Nucl Imagen Mol."},{"key":"10.1016\/j.remn.2017.10.001_bib0180","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s12149-016-1078-7","article-title":"Acquisition with (11)C-choline and (18)F-fluorocholine PET\/CT for patients with biochemical recurrence of prostate cancer: A systematic review and meta-analysis","volume":"30","author":"Von Eyben","year":"2016","journal-title":"Ann Nucl Med."},{"key":"10.1016\/j.remn.2017.10.001_bib0185","doi-asserted-by":"crossref","first-page":"56","DOI":"10.5603\/NMR.2015.0015","article-title":"The nonspecific lymph node uptake of 18F-choline in patients with prostate cancer. A prospective observational study","volume":"18","author":"Golubi\u0107","year":"2015","journal-title":"Nucl Med Rev Cent East Eur."},{"key":"10.1016\/j.remn.2017.10.001_bib0190","first-page":"238","article-title":"Salvage radiotherapy in prostate cancer patients. Planning, treatment response and prognosis using (11)C-choline PET\/CT","volume":"35","author":"Garc\u00eda","year":"2016","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"10.1016\/j.remn.2017.10.001_bib0195","author":"Mohler","year":"2017","journal-title":"NCCN clinical practice guidelines in oncology (NCCN guidelines): Prostate cancer, version 2"},{"key":"10.1016\/j.remn.2017.10.001_bib0200","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.clon.2009.10.015","article-title":"A systematic review of the role of imaging before salvage radiotherapy for post-prostatectomy biochemical recurrence","volume":"22","author":"Beresford","year":"2010","journal-title":"Clin Oncol (R Coll Radiol)."},{"key":"10.1016\/j.remn.2017.10.001_bib0205","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.2967\/jnumed.114.138313","article-title":"Early biochemical relapse after radical prostatectomy: which prostate cancer patients may benefit from a restaging 11C-choline PET\/CT scan before salvage radiation therapy?","volume":"55","author":"Castellucci","year":"2014","journal-title":"J Nucl Med."},{"key":"10.1016\/j.remn.2017.10.001_bib0210","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2967\/jnumed.113.123018","article-title":"Detection of recurrent prostate cancer after radical prostatectomy: Comparison of 11C-choline PET\/CT with pelvic multiparametric MR imaging with endorectal coil","volume":"55","author":"Kitajima","year":"2014","journal-title":"J Nucl Med."},{"key":"10.1016\/j.remn.2017.10.001_bib0215","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1007\/s00259-014-2872-x","article-title":"Impact of 11C-choline PET\/CT on clinical decision making in recurrent prostate cancer: Results from a retrospective two-centre trial","volume":"41","author":"Ceci","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remn.2017.10.001_bib0220","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1007\/s00259-015-3042-5","article-title":"(18)F-fluorocholine PET\/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide","volume":"42","author":"De Giorgi","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remn.2017.10.001_bib0225","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2967\/jnumed.113.123380","article-title":"11C-choline PET\/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy","volume":"55","author":"Giovacchini","year":"2014","journal-title":"J Nucl Med."},{"key":"10.1016\/j.remn.2017.10.001_bib0230","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00259-015-3015-8","article-title":"[11C] Choline PET\/CT predicts survival in hormone-na\u00efve prostate cancer patients with biochemical failure after radical prostatectomy","volume":"42","author":"Giovacchini","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remn.2017.10.001_bib0235","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s11604-011-0570-1","article-title":"Role of 11C-choline positron emission tomography\/computed tomography in evaluating patients affected by prostate cancer with suspected relapse due to prostate-specific antigen elevation","volume":"29","author":"Bertagna","year":"2011","journal-title":"Jpn J Radiol."},{"key":"10.1016\/j.remn.2017.10.001_bib0240","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00259-007-0581-4","article-title":"The detection rate of [11C]choline-PET\/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer","volume":"35","author":"Krause","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remn.2017.10.001_bib0245","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.eururo.2016.08.002","article-title":"EAU-ESTRO-SIOG guidelines on prostate cancer, Part II: Treatment of relapsing, metastatic, and castration-resistant prostate cancer","volume":"71","author":"Cornford","year":"2017","journal-title":"Eur Urol."},{"key":"10.1016\/j.remn.2017.10.001_bib0250","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00259-010-1604-0","article-title":"Is there a role for 11C-choline PET\/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng\/ml?","volume":"38","author":"Castellucci","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remn.2017.10.001_bib0255","doi-asserted-by":"crossref","first-page":"e342","DOI":"10.1097\/RLU.0b013e31829af913","article-title":"The role of 11C-choline PET imaging in the early detection of recurrence in surgically treated prostate cancer patients with very low PSA level <0.5 ng\/ml","volume":"38","author":"Mamede","year":"2013","journal-title":"Clin Nucl Med."},{"key":"10.1016\/j.remn.2017.10.001_bib0260","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.2967\/jnumed.108.061507","article-title":"Influence of trigger PSA and PSA kinetics on 11C-choline PET\/CT detection rate in patients with biochemical relapse after radical prostatectomy","volume":"50","author":"Castellucci","year":"2009","journal-title":"J Nucl Med."},{"key":"10.1016\/j.remn.2017.10.001_bib0265","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1007\/s00259-015-3306-0","article-title":"PET\/CT with (18)F-choline after radical prostatectomy in patients with PSA \u2264\u00a02\u00a0ng\/ml. Can PSA velocity and PSA doubling time help in patient selection?","volume":"43","author":"Chiaravalloti","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remn.2017.10.001_bib0270","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1515\/cclm-2013-0675","article-title":"Relationship between prostate-specific antigen kinetics and detection rate of radiolabelled choline PET\/CT in restaging prostate cancer patients: A meta-analysis","volume":"52","author":"Treglia","year":"2014","journal-title":"Clin Chem Lab Med."},{"key":"10.1016\/j.remn.2017.10.001_bib0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.euf.2016.11.002","article-title":"68Ga-labeled prostate specific membrane antigen ligand positron emission tomography\/computed tomography for prostate cancer: A systematic review and meta-analysis","author":"Von Eyben","year":"2016","journal-title":"Eur Urol Focus."},{"key":"10.1016\/j.remn.2017.10.001_bib0280","doi-asserted-by":"crossref","first-page":"668","DOI":"10.2967\/jnumed.115.154153","article-title":"Evaluation of hybrid 68Ga-PSMA ligand PET\/CT in 248 patients with biochemical recurrence after radical prostatectomy","volume":"56","author":"Eiber","year":"2015","journal-title":"J Nucl Med."},{"key":"10.1016\/j.remn.2017.10.001_bib0285","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2967\/jnumed.115.160382","article-title":"Prospective comparison of 18F-fluoromethylcholine versus 68Ga-PSMA\u00a0PET\/CT in prostate cancer patients who have rising PSA after curative treatment and are being considered for targeted therapy","volume":"56","author":"Morigi","year":"2015","journal-title":"J Nucl Med."},{"key":"10.1016\/j.remn.2017.10.001_bib0290","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00259-016-3490-6","article-title":"Comparison of 68Ga-labelled PSMA and 11C-choline in the detection of prostate cancer metastases by PET\/CT","volume":"44","author":"Schwenck","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253654X17301622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253654X17301622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T03:28:47Z","timestamp":1535254127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2253654X17301622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S2253654X17301622"],"URL":"https:\/\/doi.org\/10.1016\/j.remn.2017.10.001","relation":{},"ISSN":["2253-654X"],"issn-type":[{"value":"2253-654X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aportaci\u00f3n de la PET\/TC con 11C-colina en la recidiva bioqu\u00edmica del c\u00e1ncer de pr\u00f3stata con ant\u00edgeno espec\u00edfico prost\u00e1tico s\u00e9rico inferior a 1 ng\/ml","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.remn.2017.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Espa\u00f1a, S.L.U. y SEMNIM. All rights reserved.","name":"copyright","label":"Copyright"}]}}